Drug fusions and conjugates

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61P 3/10 (2006.01) C07K 16/18 (2006.01)

Patent

CA 2756853

The present invention relates to drug fusions that have improved serum half lives. These fusions and conjugates comprise polypeptides, immunoglobulin (antibody) single variable domains and GLP and/or exendin molecules. The invention further relates to uses, formulations, compositions and devices comprising such drug fusions and conjugates.

La présente invention concerne des fusions de médicament qui possèdent des demi-vies sériques améliorées. Lesdites fusions et lesdits conjugués comprennent des polypeptides, des domaines variables uniques d'immunoglobuline (anticorps) et des molécules d'exendine et/ou de GLP. L'invention concerne en outre des utilisations, des formulations, des compositions et des dispositifs comprenant de telles fusions de médicaments et de tels conjugués.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Drug fusions and conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug fusions and conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug fusions and conjugates will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1402880

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.